Answer
RoActemra (tocilizumab) is indicated to treat COVID-19 in adults who are receiving systemic corticosteroids and require supplemental oxygen or mechanical ventilation.
Sources for this answer
- RoActemra 20mg/ml Concentrate for Solution for InfusionRoche Products Limited · emc · SmPC §4.1 Therapeutic Indications · Version 37Document updated
Sources checked